PL336233A1 - Compounds and agents for treating diseases associated with serinic protease activity, in particular tryptase activity - Google Patents
Compounds and agents for treating diseases associated with serinic protease activity, in particular tryptase activityInfo
- Publication number
- PL336233A1 PL336233A1 PL97336233A PL33623397A PL336233A1 PL 336233 A1 PL336233 A1 PL 336233A1 PL 97336233 A PL97336233 A PL 97336233A PL 33623397 A PL33623397 A PL 33623397A PL 336233 A1 PL336233 A1 PL 336233A1
- Authority
- PL
- Poland
- Prior art keywords
- activity
- serinic
- agents
- compounds
- diseases associated
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title 1
- 239000004365 Protease Substances 0.000 title 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title 1
- 102000001400 Tryptase Human genes 0.000 title 1
- 108060005989 Tryptase Proteins 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83367497A | 1997-04-07 | 1997-04-07 | |
| PCT/US1997/021849 WO1998045275A1 (en) | 1997-04-07 | 1997-12-01 | Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL336233A1 true PL336233A1 (en) | 2000-06-19 |
Family
ID=25264996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL97336233A PL336233A1 (en) | 1997-04-07 | 1997-12-01 | Compounds and agents for treating diseases associated with serinic protease activity, in particular tryptase activity |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1019382A1 (en) |
| JP (1) | JP2001519806A (en) |
| KR (1) | KR20010006119A (en) |
| CN (1) | CN1251579A (en) |
| AU (1) | AU752064B2 (en) |
| CA (1) | CA2285454A1 (en) |
| EE (1) | EE04055B1 (en) |
| HU (1) | HUP0001522A3 (en) |
| LT (1) | LT4704B (en) |
| LV (1) | LV12495B (en) |
| NO (1) | NO314183B1 (en) |
| NZ (1) | NZ500029A (en) |
| PL (1) | PL336233A1 (en) |
| SI (1) | SI20115A (en) |
| SK (1) | SK136799A3 (en) |
| WO (1) | WO1998045275A1 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6221914B1 (en) | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
| AU1608399A (en) * | 1997-11-26 | 1999-06-15 | Axys Pharmaceuticals, Inc. | Substituted amidinoaryl derivatives and their use as anticoagulants |
| WO1999026932A1 (en) * | 1997-11-26 | 1999-06-03 | Axys Pharmaceuticals, Inc. | By amidino group substituted heterocyclic derivatives and their use as anticoagulants |
| GT199900167A (en) * | 1998-10-01 | 2001-03-21 | NEW BIS-BENZIMIDAZOLES. | |
| WO2000020400A1 (en) * | 1998-10-05 | 2000-04-13 | Axys Pharmaceuticals, Inc. | Novel compounds and compositions for treating hepatitis c infections |
| CA2375843A1 (en) * | 1999-06-04 | 2000-12-14 | Qi Zhao | Compositions and methods for inhibiting cell death |
| DE19953899A1 (en) * | 1999-11-10 | 2001-05-17 | Boehringer Ingelheim Pharma | Carboxamide-substituted benzimidazole derivatives, process for their preparation and their use as medicaments |
| AU2001231030A1 (en) * | 2000-01-20 | 2001-07-31 | Amgen Inc | Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics |
| US6448281B1 (en) * | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
| DE10048715A1 (en) * | 2000-09-30 | 2004-05-19 | Grünenthal GmbH | Use of amino acid for the treatment of pain |
| JP4176477B2 (en) * | 2001-03-01 | 2008-11-05 | 塩野義製薬株式会社 | Nitrogen-containing aromatic heterocyclic derivatives having HIV integrase inhibitory activity |
| GB0406282D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
| US8759535B2 (en) | 2010-02-18 | 2014-06-24 | High Point Pharmaceuticals, Llc | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
| CN102762101B (en) | 2010-02-18 | 2014-09-17 | 高点制药有限责任公司 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
| DE102011111991A1 (en) | 2011-08-30 | 2013-02-28 | Lead Discovery Center Gmbh | New cyclosporin derivatives |
| UA116336C2 (en) * | 2011-11-29 | 2018-03-12 | Перосфіе Фармасьютікалз Інк. | Anticoagulant reversal agents |
| WO2016089648A1 (en) | 2014-12-01 | 2016-06-09 | Vtv Therapeutics Llc | Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof |
| EP3974434A4 (en) * | 2019-05-21 | 2023-11-08 | Zhejiang Hisun Pharmaceutical Co., Ltd. | Macrolide derivatives, preparation method and application thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3105837A (en) * | 1961-10-20 | 1963-10-01 | Upjohn Co | 2, 2'-alkylenebisbenzimidazoles |
| US3210370A (en) * | 1964-06-22 | 1965-10-05 | Upjohn Co | Process for preparing 2, 2'-methylene-bisareneimiazoles |
| EP0720603A1 (en) * | 1993-09-22 | 1996-07-10 | The Wellcome Foundation Limited | Bis(amidinobenzimidazolyl)alkanes as antiviral agents |
| US6815461B1 (en) * | 1994-01-20 | 2004-11-09 | The University Of North Carolina At Chapel Hill | Method of inhibiting retroviral integrase |
| US5693515A (en) * | 1995-04-28 | 1997-12-02 | Arris Pharmaceutical Corporation | Metal complexed serine protease inhibitors |
-
1997
- 1997-12-01 EP EP97954520A patent/EP1019382A1/en not_active Withdrawn
- 1997-12-01 JP JP54273998A patent/JP2001519806A/en active Pending
- 1997-12-01 EE EEP199900477A patent/EE04055B1/en not_active IP Right Cessation
- 1997-12-01 SI SI9720094A patent/SI20115A/en unknown
- 1997-12-01 AU AU58950/98A patent/AU752064B2/en not_active Ceased
- 1997-12-01 CN CN97182098A patent/CN1251579A/en active Pending
- 1997-12-01 HU HU0001522A patent/HUP0001522A3/en unknown
- 1997-12-01 KR KR1019997009197A patent/KR20010006119A/en not_active Application Discontinuation
- 1997-12-01 SK SK1367-99A patent/SK136799A3/en unknown
- 1997-12-01 CA CA002285454A patent/CA2285454A1/en not_active Abandoned
- 1997-12-01 PL PL97336233A patent/PL336233A1/en unknown
- 1997-12-01 NZ NZ500029A patent/NZ500029A/en unknown
- 1997-12-01 WO PCT/US1997/021849 patent/WO1998045275A1/en not_active Application Discontinuation
-
1999
- 1999-10-06 NO NO19994858A patent/NO314183B1/en unknown
- 1999-11-02 LV LVP-99-153A patent/LV12495B/en unknown
- 1999-11-05 LT LT99-131A patent/LT4704B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| LV12495B (en) | 2001-01-20 |
| HUP0001522A3 (en) | 2001-08-28 |
| NO314183B1 (en) | 2003-02-10 |
| AU5895098A (en) | 1998-10-30 |
| NO994858D0 (en) | 1999-10-06 |
| WO1998045275A1 (en) | 1998-10-15 |
| NZ500029A (en) | 2001-02-23 |
| CN1251579A (en) | 2000-04-26 |
| LT4704B (en) | 2000-09-25 |
| EE04055B1 (en) | 2003-06-16 |
| AU752064B2 (en) | 2002-09-05 |
| JP2001519806A (en) | 2001-10-23 |
| SI20115A (en) | 2000-06-30 |
| LV12495A (en) | 2000-06-20 |
| EP1019382A1 (en) | 2000-07-19 |
| NO994858L (en) | 1999-12-06 |
| HUP0001522A2 (en) | 2001-05-28 |
| LT99131A (en) | 2000-04-25 |
| KR20010006119A (en) | 2001-01-26 |
| SK136799A3 (en) | 2000-07-11 |
| EE9900477A (en) | 2000-06-15 |
| CA2285454A1 (en) | 1998-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL336233A1 (en) | Compounds and agents for treating diseases associated with serinic protease activity, in particular tryptase activity | |
| PL331465A1 (en) | Novel compounds and agents for treating diseases associated with triptase activity | |
| ZA9711029B (en) | Therapeutic agents. | |
| GB9725782D0 (en) | Therapeutic agents | |
| MXPA02006325A (en) | Precutter and edger machine. | |
| GB9704948D0 (en) | Therapeutic agents | |
| EP0685219A3 (en) | Hair treatment agent and process for its use. | |
| GB9711753D0 (en) | Therapeutic agents | |
| HUP0001294A3 (en) | Heterocycleketo hydrazide derivatives having protease inhibitor activity, process for their preparation and their use | |
| GB9715977D0 (en) | Therapeutic agents | |
| GB9702392D0 (en) | Therapeutic agents | |
| EP0921803A4 (en) | Methods for preventing and treating pestivirus infection and associated diseases | |
| ZA9710181B (en) | Method and composition for enhancing biocidal activity. | |
| GB9725126D0 (en) | Therapeutic agents | |
| GB9706332D0 (en) | Improvements in aprons | |
| GB9718254D0 (en) | Therapeutic agents | |
| GB9716463D0 (en) | Therapeutic agents | |
| HK1003896A1 (en) | Protein having tpo activity | |
| LT99019A (en) | Novel compounds and compositions for treating diseases associated with tryptase activity | |
| GB9704073D0 (en) | Lyocell fabric treatment | |
| HUP9900942A3 (en) | Medicament forms constituted in situ for releasing enzymes into wounds | |
| HK1004410A1 (en) | Protein having tpo activity. | |
| PL303548A1 (en) | Method of prolongedly cannulating the pancreas, in particular that of swine, and cannule therefor | |
| ZA99132B (en) | Therapeutic agents. | |
| GB9916156D0 (en) | Biological and therapeutically active agents |